What's this? A dorothy dixer selfie?
No-one gives a toss that you think DMX200 is 'inferior' if you don't preface your conclusion with compelling scientific arguments that counter those very different opinions of all the PhD's employed by Advanz (who have acted on their DD), Dimerix, the Clinical Advisory Board, the IDMC and the big pharma's who have tabled term sheets for DXB's consideration !
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-47
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.010(2.60%) |
Mkt cap ! $208.9M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 37.0¢ | $687.3K | 1.820M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 411730 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 177132 | 5 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |